Literature DB >> 8413322

Post-translational processing of a major histocompatibility complex-encoded proteasome subunit, LMP-2.

C K Martinez1, J J Monaco.   

Abstract

Proteasomes are abundant, multisubunit protein complexes found in the cytoplasm and nucleus of eukaryotic cells that catalyze both ubiquitin-dependent and ubiquitin-independent protein degradation. In addition to their role in normal protein turnover, proteasomes are believed to be involved in the production of most antigenic peptides presented to T cells by major histocompatibility complex (MHC) class I molecules. A distinct subset of mouse proteasomes contain a subunit called LMP-2, which is encoded within the MHC. Here we demonstrate that a previously isolated proteasome cDNA clone encodes the LMP-2 subunit, and that two distinct forms of this subunit may be found in the proteasome complex. One form probably corresponds to the primary translation product, whereas the second form appears to be post-translationally processed by removal of the amino-terminal 20 amino acids. Determination of the location of intron/exon boundaries in the Lmp-2 gene indicated that these residues correspond precisely to the first exon of the gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413322     DOI: 10.1016/0161-5890(93)90136-y

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

1.  Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A.

Authors:  Show-Mei Chuang; Li Chen; David Lambertson; Monika Anand; Terri Goss Kinzy; Kiran Madura
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

2.  Characterization and mapping of the gene encoding mouse proteasome subunit DELTA (Lmp19).

Authors:  E C Woodward; J J Monaco
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits.

Authors:  T A Griffin; D Nandi; M Cruz; H J Fehling; L V Kaer; J J Monaco; R A Colbert
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.